OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Chemistry is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Commentary on A Differential Diagnosis of Thrombotic Microangiopathy in a 7-Year-Old Girl	155
Persistently Positive Urine Amphetamines Confirmation Testing	119
Clinical Chemistry’s Invited Reviewers 2021	115
Commentary on Understanding Elevated Vitamin D Measurements to Uncover Hypercalcemia Etiology	92
Are Anti-Receptor–Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?	83
Low Free T4 in a 13-Year-Old Girl with Short Stature and Blurry Vision	80
Correction to: Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests	76
Clinical Chemistry's Invited Reviewers 2024	74
Cardiac Troponin I or T for the Diagnosis of Myocardial Infarction and Prediction of Outcomes—Does It Matter?	68
B-117 Inverse Association Between Regulatory T and B Cells with HLA antibodies and Donor-specific Antibodies in Kidney Transplantation	65
B-278 Xylazine Detection in Clinical Urine Specimens Ordered for Comprehensive Drug Screening	64
A-172 Graphical contribution and CBC of BC-6800Plus hematology analyzer in a case of Myelodisplastic Syndrome related to Chemotherapy and Radiotherapy	61
B-043 Clinical performance evaluation of the ABD PAD® as confirmatory testing of blood group	58
A-181 Stability of urine in the BD Vacutainer® Plus Conical Urinalysis Preservative Tubes for Chemical and Microscopic Urinalysis	58
A-312 Evaluation of the Analytical Performance of the Hepatitis B Surface Antigen and confirmatory assays on the Atellica CI Analyzer	56
B-007 Activin A is a potential mediator of TGFß1-induced tubulointerstitial fibrosis	55
B-088 Stability Assessment of Hormones and Tumor Markers: Can We Ensure High-Quality Patient Results Despite Operational Challenges?	54
B-277 Validation of an Enzymatic Method for Quantification of Ethylene Glycol in Human Serum	53
B-214 Migration of a Previously Validated Sequencing Workflow of 4,700 Genes Associated with Clinical Phenotypes to the MGI DNBSEQ-G400 Platform: High-Quality NGS Data with Elevated Concordance to Exp	53
B-182 Evaluating Clinical Biochemical Diagnostic Approaches for Mitochondrial Diseases	48
A-072 The Impact of Short and Prolonged Fasting on Routine Lab Tests	47
A-050 The Role of Gut Microbial Metabolite Trimethylamine N-Oxide in Adrenal Cholesterol Homeostasis	46
A-034 Prevention of Obesity and Metabolic Disorders Through a Gut Microbial Metabolite Derived from Polyphenol Supplementation in a High-Fat Diet	45
A-154 Reduction in Turnaround Time Achieved by Simplifying Hematology Middleware Rules	43
A-170 CBC Results, flags and scattergram using BC 6800Plus Hematology Analyzer, for a case of Burkitt*s lymphoma in leukemic phase	42

A-213 Highlights on Daily Internal Quality Controls for Improved Analytical Performance in Clinical Laboratory	41
A-268 Evaluation of NAAT Recovery of Highly Pathogenic Avian Influenza A (H5N1) Clade 2.3.4.4b from Novel Proficiency Samples	40
A-032 Evaluation of the Analytical Performance of Total Triiodothyronine (T3) and Total Thyroxine (T4) Assays on the Atellica CI Analyzer	37
A-291 Rapidly Ruling Out Bacterial Infection: A Novel Host-Protein Assay for Patients with Suspected Respiratory Tract Infections in the Emergency Department	36
Correlations Within and Between Highly Multiplexed Proteomic Assays of Human Plasma	35
Cerebrospinal Fluid Homovanillic and 5-Hydroxyindoleacetic Acids in a Large Pediatric Population; Establishment of Reference Intervals and Impact of Disease and Medication	34
A-125 Difference Between the Results of Vitros® Dry Biochemistry and Wet Biochemistry with Kinetic Method in Diagnosing the Comorbidity of Lung Adenocarcinoma and Aacroamylasemia: Case Report	33
A-249 Theranostic Algorithm: sensitivity and Specificity of a Composite Index Test for Guiding Treatment in Severe COVID-19	33
A-194 Intravenous Fluid Contamination of Basic Metabolic Panels Is Underrecognized by Manual Workflows	33
B-314 Utility of he4 in differential diagnosis of pleural effusions	33
B-048 Proposal of a new monitoring algorythm for patients with a HIV positive result with the Elecsys HIV DUO test	33